{"DataElement":{"publicId":"2861466","version":"1","preferredName":"Disease or Disorder Cytogenetic Analysis Method Type","preferredDefinition":"A description of the cytogenetic testing method used to assess the disease.","longName":"2861462v1.0:2861464v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2861462","version":"1","preferredName":"Disease or Disorder Cytogenetic Analysis Method","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities._A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","longName":"DIS_CYTO_ANA_MTHD","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2404658","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"005AD6E5-0651-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"PWEST","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2782517","version":"1","preferredName":"Cytogenetic Analysis Method","preferredDefinition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.:A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","longName":"C18280:C71460","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytogenetic Analysis","conceptCode":"C18280","definition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Method","conceptCode":"C71460","definition":"A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"567BE225-9CFE-5DF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2008-09-09","modifiedBy":"ONEDATA","dateModified":"2008-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"67C29AD3-449D-DC20-E040-BB89AD4301AC","latestVersionIndicator":"Yes","beginDate":"2009-04-17","endDate":null,"createdBy":"CZECHS","dateCreated":"2009-04-17","modifiedBy":"SOKKERL","dateModified":"2017-08-25","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2861464","version":"1","preferredName":"Cytogenetic Analysis Method Type","preferredDefinition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities._A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal._Type; a subdivision of a particular kind of thing.","longName":"2861464v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Conventional cytogenetics","valueDescription":"Chromosome Banding","ValueMeaning":{"publicId":"2862254","version":"1","preferredName":"Chromosome Banding","longName":"2862254","preferredDefinition":"The treatment of chromosomes to reveal characteristic patterns of horizontal bands.  The banding patterns lend each chromosome a distinctive appearance so the 22 pairs of human nonsex chromosomes and the X and Y chromosomes can be identified and distinguished without ambiguity. Banding also permits the recognition of chromosome deletions (lost segments), chromosome duplications (surplus segments) and other types of structural rearrangements of chromosomes. (MedicineNet.com)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chromosome Banding","conceptCode":"C16437","definition":"The treatment of chromosomes to reveal characteristic patterns of horizontal bands.  The banding patterns lend each chromosome a distinctive appearance so the 22 pairs of human non-sex chromosomes and the X and Y chromosomes can be identified and distinguished without ambiguity. Banding also permits the recognition of chromosome deletions (lost segments), chromosome duplications (surplus segments) and other types of structural rearrangements of chromosomes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"682A552E-41E8-E53B-E040-BB89AD4350EB","latestVersionIndicator":"Yes","beginDate":"2009-04-22","endDate":null,"createdBy":"CZECHS","dateCreated":"2009-04-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"682A552E-4200-E53B-E040-BB89AD4350EB","beginDate":"2009-04-22","endDate":null,"createdBy":"CZECHS","dateCreated":"2009-04-22","modifiedBy":"ONEDATA","dateModified":"2009-04-22","deletedIndicator":"No"},{"value":"FISH","valueDescription":"Fluorescence in situ Hybridization","ValueMeaning":{"publicId":"2862253","version":"1","preferredName":"Fluorescence in situ Hybridization","longName":"2862253","preferredDefinition":"A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fluorescence In Situ Hybridization","conceptCode":"C17563","definition":"A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"682A552E-41C6-E53B-E040-BB89AD4350EB","latestVersionIndicator":"Yes","beginDate":"2009-04-22","endDate":null,"createdBy":"CZECHS","dateCreated":"2009-04-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B0618532-9E78-D5C5-E040-BB89AD431905","beginDate":"2009-04-22","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-10-28","modifiedBy":"ONEDATA","dateModified":"2011-10-28","deletedIndicator":"No"},{"value":"Karyotyping","valueDescription":"Karyotyping","ValueMeaning":{"publicId":"5095203","version":"1","preferredName":"Karyotyping","longName":"5095203","preferredDefinition":"The preparation, analysis, and interpretation of a karyotype, the representation of the chromosome set of a cell.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Karyotyping","conceptCode":"C16768","definition":"The preparation, analysis, and interpretation of a karyotype, the representation of the chromosome set of a cell.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"280CB7B5-C81B-43D4-E050-BB89AD4365A7","latestVersionIndicator":"Yes","beginDate":"2015-12-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"280CB7B5-C834-43D4-E050-BB89AD4365A7","beginDate":"2015-12-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-12-29","modifiedBy":"ONEDATA","dateModified":"2015-12-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3302918","version":"1","preferredName":"Cytogenetic Analysis Method Type","preferredDefinition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.:A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.:Type; a subdivision of a particular kind of thing.","longName":"C18280:C71460:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytogenetic Analysis","conceptCode":"C18280","definition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Method","conceptCode":"C71460","definition":"A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B150DC18-93FD-4A09-E040-BB89AD43627C","latestVersionIndicator":"Yes","beginDate":"2011-11-09","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-11-09","modifiedBy":"ONEDATA","dateModified":"2011-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"67C29AD3-44CC-DC20-E040-BB89AD4301AC","latestVersionIndicator":"Yes","beginDate":"2009-04-17","endDate":null,"createdBy":"CZECHS","dateCreated":"2009-04-17","modifiedBy":"KUMMEROA","dateModified":"2015-12-29","changeDescription":". Corrected spelling in def. AK 11/314  Added PV \"karyotyping\" for 2450r4. AK 12/29/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964903","version":"1","longName":"2110r1: Acute Myelogenous Leukemia Post-HSCT Data","context":"NHLBI"},{"publicId":"2964904","version":"1","longName":"2111r1: All Post-HSCT Data","context":"NHLBI"},{"publicId":"2964905","version":"1","longName":"2112r1: CML Post-HSCT Data","context":"NHLBI"},{"publicId":"3279271","version":"1","longName":"Disease Status","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"PerformedObservation:methodCode","type":"HCT_BRIDG","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What method was used for cyto","type":"Preferred Question Text","description":"What method was used for cytogenetic analysis?","url":null,"context":"NHLBI"},{"name":"Specify the cytogenetic assessment method(s) used to assess the disease status:","type":"Alternate Question Text","description":"Specify the cytogenetic assessment method(s) used to assess the disease status:","url":null,"context":"NHLBI"},{"name":"BRIDG mapping for CDE:2861466","type":"BRIDG Mapping Path","description":"PerformedObservation.methodCode WHERE  DefinedObservation.nameCode = \"Perform cytogenetic analysis\"","url":null,"context":"NHLBI"},{"name":"What method was used for cytogenetic testing?","type":"Alternate Question Text","description":"What method was used for cytogenetic testing?","url":null,"context":"NHLBI"},{"name":"What cytogenetic assessment method was used to assess the disease status?","type":"Alternate Question Text","description":"What cytogenetic assessment method was used to assess the disease status?","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"67C29AD3-452A-DC20-E040-BB89AD4301AC","latestVersionIndicator":"Yes","beginDate":"2009-04-17","endDate":null,"createdBy":"CZECHS","dateCreated":"2009-04-17","modifiedBy":"ALEYR","dateModified":"2019-04-07","changeDescription":". .1/8/14mn-added Bridg info. Added human readable def. System generated def displayed as alt def. No version needed. AK 11/3/14 Added AQT per 2110 FB review. AK 11/11/14 Updated CDE with added PV. AK 12/29/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}